aa36523c-671a-47b0-964e-cd6d85cbcecfQ1 — 1st Quarter - Reportlobbying firm
TAX — Taxation/Internal Revenue CodeIssues related to coverage of over-the-counter products with FSAs and HSAs.
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
BUD — Budget/AppropriationsPolicies impacting access to over-the-counter products; FY2026 Financial Services and General Government Appropriations Act process (H.R.5166/S.3290); H.R.7148, Making further consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes (P.L.119-75).
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
TRD — Trade (domestic/foreign)Policies impacting the supply chain and manufacturing of over-the-counter pharmaceutical products including tariffs.
Government entities lobbied: Bureau of Industry and Security (BIS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE
MMM — Medicare/MedicaidEducation about the importance of OTC products and benefits under Medicare Advantage.
Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE
HCR — Health IssuesIssues related to healthcare and payment for over-the-counter drugs; General education of over-the-counter switches, including reauthorization of the Over-the-Counter Monograph Drug User Fee Act and policies impacting a Nonprescription Drug Product with an Additional Condition for Nonprescription Use.
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.